# US 2008/0075753 A1 · Multi-layered coatings and methods for controlling elution of active agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0075753 A1
- Document ID: US20080075753A1
- Status: Published application
- Kind: A1
- Application number: 11/860,856
- Filed: 2007-09-25
- Published: 2008-03-27
- Earliest claimed: 2006-09-25
- Inventors: Ralph A. Chappa
- Web page: https://patentgrep.com/patent/US20080075753A1

## CPC

- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 27/34: Macromolecular materials
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 31/10: Macromolecular materials
- A61L 2300/608: having two or more layers
- A61L 2420/08: Coatings comprising two or more layers
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Embodiments of the invention include multi-layered coatings for controlling the elution rates of active agents and methods. In an embodiment, the invention includes a method of applying an elution control coating to a substrate. The method can include depositing a coating solution onto the substrate to form a base layer. The method can also include selecting a desired concentration of the solvent based on a desired elution rate. The method can further include removing solvent from the base layer to reach a desired concentration of the solvent and depositing a layer of parylene on the base layer. In an embodiment, the invention can include a medical device including a substrate, a base layer, and a porous layer. The base layer can include a polymeric matrix and an active agent dispersed within the polymeric matrix. The porous layer can include parylene. Other embodiments are also included herein.

## Claims

### Claim 1

A method of applying an elution control coating to a substrate comprising:
depositing a coating solution onto the substrate to form a base layer, the coating solution comprising an active agent, a polymer, and a solvent;
selecting a desired concentration of the solvent based on a desired elution rate;
removing solvent from the base layer to reach a desired concentration of the solvent; and
depositing a layer of parylene on the base layer.

### Claim 2 (depends on 1)

The method of claim 1, wherein depositing a coating solution onto the substrate to form a base layer comprises spraying a coating solution onto the substrate.

### Claim 3 (depends on 1)

The method of claim 1, the active agent comprising a macromolecule.

### Claim 4 (depends on 1)

The method of claim 1, the active agent selected from the group consisting of peptides and proteins.

### Claim 5 (depends on 1)

The method of claim 1, the active agent selected from the group consisting of antibodies and antibody derivatives.

### Claim 6 (depends on 1)

The method of claim 1, the solvent comprising a non-polar solvent.

### Claim 7 (depends on 1)

The method of claim 1, the solvent comprising a polar solvent.

### Claim 8 (depends on 1)

The method of claim 1, wherein depositing a coating solution onto a substrate to form a base layer comprises simultaneously spraying a first coating solution onto the substrate from a first spray head and spraying a second coating solution onto the substrate from a second spray head.

### Claim 9 (depends on 8)

The method of claim 8, the first coating solution comprising the active agent and the second coating solution comprising the polymer.

### Claim 10 (depends on 1)

The method of claim 1, the polymer comprising a degradable polymer and a non-degradable polymer, the first coating solution comprising the degradable polymer and the active agent and the second coating solution comprising non-degradable polymer.

### Claim 11 (depends on 1)

The method of claim 1, wherein removing solvent from the base layer comprises inserting the base layer and the substrate into a vacuum chamber.

### Claim 12 (depends on 1)

The method of claim 1, wherein removing solvent from the base layer comprises inserting the base layer and the substrate into a vacuum chamber for a period of time greater than about 30 minutes.

### Claim 13

A method of depositing a multi-layer elution control coating onto a substrate comprising:
depositing a coating solution onto the substrate to form a base layer, the coating solution comprising an active agent, a polymer, and a solvent;
storing the substrate and base layer under vacuum for a period of time greater than about 30 minutes to form a degassed base layer; and
depositing a layer of parylene on the degassed base layer.

### Claim 14

A medical device comprising:
a substrate;
a base layer disposed on the substrate, the base layer comprising a polymeric matrix and an active agent, the active agent dispersed within the polymeric matrix, the active agent selected from the group consisting of peptides, proteins, antibodies, and antibody derivatives; and
a porous layer disposed directly on the base layer, the porous layer comprising parylene.

### Claim 15 (depends on 14)

The medical device of claim 14, the base layer comprising a degradable polymer and a non-degradable polymer, the degradable polymer and the non-degradable polymer forming an interpenetrating network, the active agent dispersed within the degradable polymer.

### Claim 16 (depends on 14)

The medical device of claim 14, the polymeric matrix comprising a hydrophobic polymer.

### Claim 17 (depends on 14)

The medical device of claim 14, the polymeric matrix comprising poly-n-butylmethacrylate and polyethylene-co-vinyl acetate.

### Claim 18 (depends on 14)

The medical device of claim 14, the base layer having a thickness of between about 0.5 microns and about 100 microns.

### Claim 19 (depends on 14)

The medical device of claim 14, the top layer comprising poly(2-chloro-paraxylylene).

### Claim 20 (depends on 14)

The medical device of claim 14 configured to elute about 0.1 μg/day to about 3.0 μg/day of the peptide for a period of time of at least about 30 days.
